JK Paper Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
JKPAPER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JK Paper Limited's board, at its May 19, 2025 meeting, approved audited standalone and consolidated results for Q4 and FY25. Consolidated revenue from operations stood at approximately Rs. 7,120 Cr in FY25 vs. Rs. 7,008 Cr in FY24, while consolidated profit after tax was Rs. 411.96 Cr (FY24: Rs. 905.07 Cr; FY24 was inflated by a one-time Rs. 174.20 Cr deferred tax credit from the new tax regime). Management flagged continued pressure from high import volumes and rising wood costs, which hurt realisations. The board recommended a dividend of Rs. 5 per share (50%), totaling Rs. 84.70 Cr, and acquired two new subsidiaries — Radhesham Wellpack (Feb 2025) and Quadragen Vethealth (Mar 2025). Auditor Lodha & Co LLP issued an unmodified opinion on both sets of results.
Profitability took a hit from input cost and pricing pressures, with margins compressed despite stable topline growth on a consolidated basis. Shareholders get continued dividend support, but the new subsidiaries and pending composite scheme could provide future growth optionality; near-term sentiment may stay cautious until input costs and import pressure ease.